We are live on ! Find out more
STIM icon

Neuronetics

67 hedge funds and large institutions have $31.5M invested in Neuronetics in 2024 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 18 increasing their positions, 25 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 7

2% more funds holding

Funds holding: 6667 (+1)

1.05% less ownership

Funds ownership: 59.43%58.38% (-1%)

28% less repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 25

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

63% less capital invested

Capital invested by funds: $84.2M → $31.5M (-$52.7M)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $7K

Holders
67
Holders Change
+1
Holders Change %
+1.52%
% of All Funds
0.97%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
8
Increased
18
Reduced
25
Closed
7
Calls
Puts
$7K
Net Calls
-$7K
Net Calls Change
-$1K
Name Holding Trade Value Shares
Change
Change in
Stake
Bank of America
26
Bank of America
North Carolina
$122K -$16.5K -5,724 -8%
DJYG
27
David J. Yvars Group
Florida
$120K -$9.29K -3,220 -5%
UBS Group
28
UBS Group
Switzerland
$119K +$178K +61,665 +1,366%
Millennium Management
29
Millennium Management
New York
$106K -$22.1K -7,648 -11%
RC
30
RBF Capital
California
$106K -$4.13K -1,432 -2%
Northern Trust
31
Northern Trust
Illinois
$102K -$118 -41 -0.1%
DSCM
32
Divisadero Street Capital Management
Florida
$92.9K -$4.29M -1,487,839 -97%
GF
33
Gabelli Funds
New York
$86.4K +$64.9K +22,500 +88%
GCP
34
GSA Capital Partners
United Kingdom
$86K +$138K +47,805 New
Fidelity Investments
35
Fidelity Investments
Massachusetts
$84.1K
PCM
36
Prelude Capital Management
New York
$83.2K -$888 -308 -0.7%
Two Sigma Advisers
37
Two Sigma Advisers
New York
$78.8K -$19.6K -6,800 -13%
LCM
38
Legato Capital Management
California
$44.2K +$70.8K +24,540 New
FCG
39
Fielder Capital Group
Tennessee
$41K
FCM
40
FourWorld Capital Management
New York
$39.3K -$40.7K -14,100 -39%
Prudential Financial
41
Prudential Financial
New Jersey
$36.7K -$3.46K -1,200 -6%
QOP
42
Quinn Opportunity Partners
Virginia
$36K -$28.8K -10,000 -33%
T. Rowe Price Associates
43
T. Rowe Price Associates
Maryland
$35K
Bank of New York Mellon
44
Bank of New York Mellon
New York
$32.7K -$86.5K -30,000 -62%
TA
45
Teton Advisors
New York
$32.4K
OQS
46
Occudo Quantitative Strategies
Florida
$31.7K -$219 -76 -0.4%
WVP
47
Worth Venture Partners
New Jersey
$28.5K -$3.04K -1,055 -6%
Squarepoint
48
Squarepoint
New York
$26.6K -$15.4K -5,325 -26%
CSS
49
Cubist Systematic Strategies
Connecticut
$25.6K -$113K -39,283 -73%
Susquehanna International Group
50
Susquehanna International Group
Pennsylvania
$22.9K -$104K -36,008 -74%

STIM Hedge Fund Activity: Q2 2024 in Review

67 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Neuronetics (STIM) for Q2 2024, worth a combined $31.5M — down 63% from $84.2M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new STIM positions and 7 closed out — a net gain of 1 holder — while 18 added to existing stakes and 25 trimmed.

The largest buyer was Kent Lake Capital, adding an estimated $2.07M. The largest seller was Divisadero Street Capital Management, cutting an estimated $4.29M.

  • 67 institutional investors held Neuronetics (STIM) as of Q2 2024, up from 66 in Q1 2024.
  • Funds reported $31.5M of Neuronetics stock for Q2 2024, down 63% quarter-over-quarter.
  • 8 funds opened new Neuronetics positions in Q2 2024 and 7 closed out, a net change of +1 holder.
  • The largest Neuronetics buyer in Q2 2024 was Kent Lake Capital, an estimated $2.07M added.
  • The largest Neuronetics seller in Q2 2024 was Divisadero Street Capital Management, an estimated $4.29M sold.

Based on aggregated 13F filings for Q2 2024.